Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2016 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (263)	12/3/2016 4:52:06 PM
From: Jack Hartmann	Respond to of 311

I am interested again.

To: BulbaMan who wrote (263)	12/3/2016 5:26:42 PM
From: tuck	2 Recommendations Recommended By Lance Bredvold rkrw Respond to of 311

After a hiatus, I'm coming back. Making my list, checking it twice. I've been both naughty and nice. Cheers, Tuck

To: BulbaMan who wrote (263)	12/9/2016 9:16:34 PM
From: BulbaMan	3 Recommendations Recommended By ghmm The Ox Thehammer Read Replies (2) \| Respond to of 311

ATTENTION BIOTECHIES: I assume, despite the less than stellar performance of most Contest portfolios in 2016, there’s still interest in a 2017 Biotech Charity Contest. Please let me know if my assumption is correct. Thanks, Bulba. 12/9/16 Contest update Congress overwhelmingly approved the ‘‘21st Century Cures Act’’ last week but that wasn’t enough to cure the continued underperformance of biotech stocks. It may be biotech investors fear drugs will face competition from placebos if libertarian, Jim O’Neill, on Trump’s list for FDA chief, gets the job. Meanwhile, at Friday’s close, the Contest median was down -24.54% YTD (vs. down -25.11% YTD a week ago). The Nasdaq Biotech Index (NBI) was down -20.39% YTD (vs. down -20.07% YTD a week ago), while the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was down -11.86% YTD (vs. down -11.98% YTD a week ago). The Nasdaq Composite Index (NCI) was up 8.73% YTD (vs. up 4.96% YTD a week ago). JBOG’s portfolio, up 26.80% YTD, remained in the lead, with DNAJOE’s portfolio, up 21.30% YTD, still in second place and BIOPLAY’s’s portfolio, up 15.58% YTD, moving into third place. At Friday’s close, 7 of the 58 Contest portfolios were in the green, with 24 portfolios beating the NBI and 16 beating the SPSIBI. The 223 Contest stock picks had an average YTD loss of -17.36% and a median YTD loss of -29.49%, with 53 of the 223 Contest portfolio stocks up for the year. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week, ranked by % Gained and % Lost. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None (All corrections, especially adjustments for splits, greatly appreciated.) Enjoy a safe & fun weekend biotechies. Peace & good health, Bulba 12/9/16 Rank Name Profit/Loss 1 JBOG 26,797 2 DNAJOE 21,302 3 BIOPLAY 15,578 4 STEVEL 13,743 5 BMAZ 5,047 6 USUBAN 3,880 7 THEOX 599 8 CEMBP -2,747 9 BAGEL -3,758 10 TOMP -4,372 Week's Top 5 Gainers Symbol 12/2/16 12/9/16 Wk.%chg. SSH 0.18 0.50 177.78% MSTX 0.08 0.12 46.75% TVIA 1.15 1.55 34.78% PPHM 0.30 0.40 31.30% EBS 26.27 32.37 23.22% Week's Worst 5 Losers Symbol 12/2/16 12/9/16 Wk.%chg. GBIM 0.57 0.40 -29.82% CAPR 3.200 2.670 -16.56% RPRX 1.77 1.51 -14.69% BLCM 18.72 16.05 -14.26% CUR 0.27 0.24 -11.91%

To: BulbaMan who wrote (263)	12/17/2016 2:15:59 AM
From: BulbaMan	Read Replies (1) \| Respond to of 311

ATTENTION BIOTECHIES: Judging by the messages I’ve received, there seems to enough interest in a 2017 Biotech Charity Contest. I’ll set up the 2017 Board in the next few days. Thanks, Bulba. 12/16/16 Contest update The Fed raised the federal funds rate by a quarter percent this week. If only the jump in my blood pressure was as limited each time Trump picks a new cabinet member. Meanwhile, at Friday’s close, the Contest median was down -25.44% YTD (vs. down -24.54% YTD a week ago). The Nasdaq Biotech Index (NBI) was down -19.65% YTD (vs. down -20.39% YTD a week ago), while the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was down -11.95% YTD (vs. down -11.86% YTD a week ago). The Nasdaq Composite Index (NCI) was up 8.58% YTD (vs. up 8.73% YTD a week ago). We have a new leader! Boosted by AKAO’s big jump, STEVEL’s portfolio, up 34.53% YTD is now in first place. JBOG’s portfolio, up 26.64% YTD, dropped to second place and DNAJOE’s portfolio, up 22.01% YTD, fell to third place. At Friday’s close, 6 of the 58 Contest portfolios were in the green, with 21 portfolios beating the NBI and 15 beating the SPSIBI. The 223 Contest stock picks had an average YTD loss of -18.02% and a median YTD loss of -30.67%, with 55 of the 223 Contest portfolio stocks up for the year. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week, ranked by % Gained and % Lost. (Prices not converted to US$ in these Tables.) Portfolio adjustments: 1) APPY (Venaxis) symbol & name change to BIOP (Biopix). 2) MDGN (Medgenics) symbol & name change to GNMX (Aevi Genomic). (All corrections, especially adjustments for splits, greatly appreciated.) Have a relaxing pre-electoral college vote weekend biotechies. Peace & good health, Bulba 12/16/16 Rank Name Profit/Loss 1 STEVEL 34,534 2 JBOG 26,643 3 DNAJOE 22,010 4 BIOPLAY 16,188 5 BMAZ 2,663 6 USUBAN 1,792 7 THEOX -589 8 TOMP -4,686 9 DODGY -7,161 10 BAGEL -7,513 Week's Top 5 Gainers Symbol 12/9/16 12/16/16 Wk.%chg. AKAO 5.25 13.17 150.86% APTO 1.05 1.53 45.71% EVOK 1.54 2.07 34.42% GNMX 5.22 6.85 31.23% CUR 0.24 0.27 14.83% Week's Worst 5 Losers Symbol 12/9/16 12/16/16 Wk.%chg. OPHT 38.77 5.19 -86.61% TVIA 1.550 1.125 -27.42% MGNX 27.15 20.26 -25.38% IMMY 2.35 1.81 -22.98% IMDZ 8.30 6.40 -22.89%